[Effect of dendritic cell autovaccine on the treatment outcome in patients with ovarian cancer].

During I/II phase clinical trial in ovarian cancer (OC) patients two types of autologous anticancer vaccines based on dendritic cells have been tested, and a comparative analysis of their effectiveness have been performed. It was shown that the anticancer vaccines based on DC, "loaded" with autologous tumor cell lysate obtained by treatment of tumor cells by cytotoxic lectins B. subtilis had higher efficiency, compared with the standard DC--autovaccine.

[Hemosorption and polychemotherapy with hyperglycemia in the treatment of ovarian cancer].

Polychemotherapy supplemented by short-time artificial hyperglycemia was carried out in 54 patients with advanced ovarian cancer. For detoxication drugs were used in 27 patients and hemosorption in 27 patients. It was found that hemosorption produced a more detoxifying effect, reduces the frequency of severe complications and allows to improve long-term results.